SUB-TYPE: CLASS 3 RECALL
Accord-UK Ltd is recalling a specific batch of Co-Codamol 8/500mg Effervescent Tablets (Key Pharmaceuticals Livery) as a precautionary measure due to the internal tablet blister strips being printed with an incorrect expiry date.
Pip code | Product description | Supplier | Batch Numbers |
Alliance do not stock | CO-CODAMOL EFF TAB 8/500MG | Accord (Key livery) | G2301502 |
Further Information
For medical information enquiries please contact Accord-UK Ltd’s Medical Information Department on 01271 385257, or email medinfo@accord-healthcare.com
For stock control enquiries please contact Accord-UK Ltd’s Customer Services Team on 0800 373573, or email customerservices@accord-healthcare.com
Please return all affected stock to your original supplier for credit. Unfortunately we can only accept stock purchased from us (Alliance Healthcare Distribution Limited). Any other stock will be returned to your stores/Pharmacies.
Please note that anything not returned to us, or notified to us, within 3 months of this notification, cannot be reimbursed by way of a credit.
SUB-TYPE:
To help keep our customers informed of changes to our service, we have published our Early May 2024 bank holiday opening hours for pharmacy and retail customers.
Early May 2024 bank holiday opening hours - England, Scotland, Wales and Northern Ireland
Early May 2024 bank holiday opening hours - Channel Islands and Isle of Man
SUB-TYPE: CLASS 3 RECALL
Bristol-Myers Squibb Pharmaceuticals Limited has informed the MHRA that a potential product quality issue has been detected, relating to incomplete crimping of the metal crimp cap of OPDIVO 10mg/mL concentrate for solution for infusion (nivolumab) (1VLX10ML)
MHRA drug alert link: https://www.gov.uk/drug-device-alerts/class-3-medicines-recall-bristol-myers-squibb-pharmaceuticals-limited-opdivo-10-mg-slash-ml-concentrate-for-solution-for-infusion-nivolumab-el-24-a-slash-11
Pip code | Product Description | Affected Batches |
Alliance do not stock | OPDIVO 10 mg/mL concentrate for solution | 8053520 |
Further information
For medical information enquiries please contact the Bristol Myers Squibb Medical Information Department by phone (0800 731 1736) or email medical.information@bms.com.
Please return all affected stock to your original supplier for credit. Unfortunately we can only accept stock purchased from us (Alliance Healthcare Distribution Limited). Any other stock will be returned to your stores/Pharmacies.
Please note that anything not returned to us, or notified to us, within 3 months of this notification, cannot be reimbursed by way of a credit.
SUB-TYPE:
A new independent report commissioned by the NCHA has been released, shining new light on the value of Clinical Homecare. ‘Best Kept Secret: the value of Clinical Homecare to patients, the NHS and society’ has been steered by an independent panel of experts and shines new light on the benefits of homecare to patients, NHS and society.
Clinical Homecare can significantly enhance patients’ lives, enabling them to maintain independence, sustain relationships and pursue work or education. Clinical Homecare also provides significant financial savings and benefits to the NHS and wider society. Despite this, Clinical Homecare remains absent from long-term NHS plans, resulting in a significant missed opportunity.
Follow this link to read the full report: clinicalhomecare.org/bestkeptsecret
Alcura is proud to be a full member of the NCHA, adhering to its stringent Code of Practice and membership criteria. Our commitment to these standards ensures that we provide patients, healthcare professionals and commissioners with the assurance of rigorous excellence in all aspects of Clinical Homecare services we offer.
SUB-TYPE: CLASS 4 CAUTION IN USE
Fresenius Kabi Limited has informed the MHRA of an error on the infusion bag packaged into the specific batches of Sodium Chloride Intravenous Infusion 0.9% Freeflex.
MHRA drug alert date: 21st March 2024
MHRA drug alert link:https://www.gov.uk/drug-device-alerts/class-4-medicines-notification-fresenius-kabi-limited-sodium-chloride-intravenous-infusion-0-dot-9-percent-freeflex-el-24-a-slash-10
Pip code | Product description | Supplier | Batch Numbers |
Alliance do not stock | Sodium Chloride Intravenous Infusion 0.9% Freeflex. | Fresenius Kabi | 13SMR091 |
This is a caution in use only we are not accepting stock returns
Further information
For more information or medical information queries please email Medical.Information-UK@fresenius-kabi.com or telephone +44 (0)1928533575
For stock control enquiries please contact FK.complaints-uk@fresenius-kabi.com or telephone +44 (0) 1928 533758
SUB-TYPE: FIELD SAFETY NOTICE
Field safety notice-Carboflex dressings
We have received a recall from Convatec regarding two sizes of Carboflex dressings
Date of recall: 19/03/24
PIP CODE | DESCRIPTION | SUPPLIER | AFFECTED BATCH |
2527372 | CARBOFLEX N/ADH S7661 8X15CM | CONVATEC VIA NWOS | 3J02333 |
2527380 | CARBOFLEXN/ADH S7662 15X20CM | CONVATEC LTD (WOUNDCARE) | 3J00675 |
Please return all affected stock to your original supplier for credit. Unfortunately we can only accept stock purchased from us (Alliance Healthcare Distribution Limited). Any other stock will be returned to your stores/Pharmacies.
Please note that anything not returned to us, or notified to us, within 3 months of this notification, cannot be reimbursed by way of a credit.
SUB-TYPE: CLASS 3 RECALL
Besins Healthcare (UK) Ltd has informed the MHRA that a defective pump system was detected in two batches of Oestrogel Pump-Pack 750 micrograms/actuation Gel.
Pip code | Product description | Supplier | Batch Numbers |
2171775 | OESTROGEL CAN | BESINS HEALTHCARE (ALLFS) | 74800 74830 |
Further Information
For medical information enquiries please contact the Besins Healthcare UK Ltd Medical Information via email besins@eu.propharmagroup.com or by calling +44 (0)1748 828 789.
For stock control enquiries please contact Besins Healthcare UK Ltd Supply Chain via email supplychain-bhuk@besins-healthcare.com.
Please return all affected stock to your original supplier for credit. Unfortunately we can only accept stock purchased from us (Alliance Healthcare Distribution Limited). Any other stock will be returned to your stores/Pharmacies.
Please note that anything not returned to us, or notified to us, within 3 months of this notification, cannot be reimbursed by way of a credit.
SUB-TYPE:
We are pleased to announce that, as of 01 February 2024, Alliance Healthcare UK has become one of the chosen wholesalers to supply Opella Healthcare’s (trading as Sanofi Consumer Healthcare) consumer healthcare products to all pharmacies in the United Kingdom.
Opella Healthcare’s consumer healthcare portfolio includes the brands Cialis®Together, Allevia®, Buscopan®Dulcolax® and Phenergan®.
Click here for full product details.
SUB-TYPE: CLASS 2 RECALL
medac GmbH (t/a medac Pharma LLP) is recalling the product for the batch specified in this notification due to particles detected during long-term stability tests.
MHRA drug alert date:12/03/24
Pip code | Product description | Supplier | Batch Numbers |
ALLIANCE DO NOT STOCK | Sodiofolin 50 mg/ml, solution for injection/infusion 8ml | medac GmbH | E230320B |
Further Information
For all medical enquiries, please contact medical information at medac Pharma LLP by email to info@medacpharma.co.uk or by telephone 01786 458086
SUB-TYPE:
To help keep our customers informed of changes to our service, we have published our Easter 2024 bank holiday opening hours for pharmacy and retail customers.
Easter 2024 bank holiday opening hours - England, Scotland, Wales and Northern Ireland
Easter 2024 bank holiday opening hours - Channel Islands and Isle of Man